Last updated on November 2017

A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee


Brief description of study

A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

Detailed Study Description

The purpose of this research study is to evaluate the long-term safety and effectiveness of an investigational medication in subjects with osteoarthritis of the hip or knee.

Clinical Study Identifier: TX11215

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jay Dobson

Northwest Clinical Research Center
Bellevue, WA USA
  Connect »

Central Kentucky Research Associates

Central Kentucky Research Associates
Lexington, KY USA
  Connect »